Ophthalmic and Topical Dosage Form New Animal Drugs; Selamectin

• Date: November 05, 2009
• Source: www.fda.gov

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Pfizer, Inc. The supplemental NADA revises the minimum age of treatment from 6 weeks to 8 weeks for kittens treated with a topical selamectin solution

Effective Date:This rule is effective April 30,2009

Click here to download the file